Business Context and Reporting Period
This Form 8-K was filed by PerkinElmer, Inc. (noted as REVVITY, INC. in metadata) on July 18, 2013. The report details a material definitive agreement entered into by PerkinElmer Health Sciences, Inc., an indirect wholly owned subsidiary, regarding the sale and leaseback of a corporate facility.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale-leaseback agreement.
- Property: Facility located at 549 Albany Street, Boston, Massachusetts.
- Sale Price: $49.5 million to Senior Housing Properties Trust.
- Lease Term: Initial term of 15 years with two optional 10-year extensions.
- Initial Rent: $3.1 million annual base rent.
- Rent Escalation: 2.25% annual increase after the first year.
- Expected Closing: Third quarter of 2013.
Material Changes and Outlook
The filing does not report changes to revenue, profit, or cash flow for a specific reporting period, as this is a current report of a specific event rather than a periodic financial statement. The transaction is expected to generate immediate liquidity upon closing in Q3 2013 while maintaining the company's operational use of the facility. The filing does not provide specific guidance or management commentary beyond the transaction mechanics.
Risks and Contingencies
The transactions are subject to customary closing conditions, including the satisfactory completion of a due diligence period. If these conditions are not met, the sale and leaseback may not close as expected.
Key Facts for Investor Verification
- Verify the actual closing date and confirmation of the $49.5 million proceeds in Q3 2013 financial statements.
- Confirm the accounting treatment of the sale-leaseback transaction (e.g., recognition of gain/loss on sale).
- Monitor the impact of the new $3.1 million annual lease obligation on future operating expenses.
- Review the full Purchase and Sale Agreement (Exhibit 10.1) for specific covenants or restrictions.